#ADA2022 – Estudo randomizado | Dulaglutida semanal para tratamento de jovens com diabetes tipo 2.

Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comunicado de imprensa: Once Weekly Drug Helps Control Pediatric Type 2 Diabetes – American Diabetes Association

Comentário no Twitter

Trial compared once-weekly dulaglutide with placebo for glycemic control in youths with type 2 diabetes who may have been receiving metformin or basal insulin. Dulaglutide was superior at 26 weeks. #ADA2022 https://t.co/P6PubXvHOR pic.twitter.com/1JPIT5IyTe

— NEJM (@NEJM) June 4, 2022